VanEck Pharmaceutical ETF
47 hedge funds and large institutions have $94.5M invested in VanEck Pharmaceutical ETF in 2020 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
17% less call options, than puts
Call options by funds: $1.34M | Put options by funds: $1.62M
29% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 14
Holders
47
Holding in Top 10
–
Calls
$1.34M
Puts
$1.62M
Top Buyers
| 1 | +$41.6M | |
| 2 | +$2.26M | |
| 3 | +$804K | |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$672K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$554K |
Top Sellers
| 1 | -$5.74M | |
| 2 | -$5.46M | |
| 3 | -$5.14M | |
| 4 |
BCI
Brinker Capital Investments
Berwyn,
Pennsylvania
|
-$423K |
| 5 |
DI
DFPG Investments
Sandy,
Utah
|
-$287K |